WuXi PharmaTech (Cayman) Stock Price, News & Analysis (NYSE:WX)

$45.91 0.00 (0.00 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$45.91
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market Capitalization$3.27 billion
P/E RatioN/A
Dividend YieldN/A

About WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) logoWuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Receive WX News and Ratings via Email

Sign-up to receive the latest news and ratings for WX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$1.18
Net IncomeN/A
Net Margins7.52%
Return on Equity6.93%
Return on Assets4.67%


Outstanding SharesN/A

WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions

What is WuXi PharmaTech (Cayman)'s stock symbol?

WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."

How were WuXi PharmaTech (Cayman)'s earnings last quarter?

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) announced its earnings results on Tuesday, November, 3rd. The medical research company reported $0.31 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.31. The medical research company had revenue of $213.60 million for the quarter, compared to analyst estimates of $205.24 million. WuXi PharmaTech (Cayman) had a net margin of 7.52% and a return on equity of 6.93%. WuXi PharmaTech (Cayman)'s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.

Who are some of WuXi PharmaTech (Cayman)'s key competitors?

How do I buy WuXi PharmaTech (Cayman) stock?

Shares of WuXi PharmaTech (Cayman) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is WuXi PharmaTech (Cayman)'s stock price today?

One share of WuXi PharmaTech (Cayman) stock can currently be purchased for approximately $45.91.

How big of a company is WuXi PharmaTech (Cayman)?

WuXi PharmaTech (Cayman) has a market capitalization of $3.27 billion.

How can I contact WuXi PharmaTech (Cayman)?

WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.

MarketBeat Community Rating for WuXi PharmaTech (Cayman) (WX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  208
MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

WuXi PharmaTech (Cayman) (NYSE:WX) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


WuXi PharmaTech (Cayman) (NYSE:WX) Earnings History and Estimates Chart

Earnings by Quarter for WuXi PharmaTech (Cayman) (NYSE:WX)

WuXi PharmaTech (Cayman) (NYSE WX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2015Q3$0.31$0.31$205.24 million$213.60 millionViewN/AView Earnings Details
8/13/2015Q215$0.39$0.38$195.26 million$194.14 millionViewListenView Earnings Details
5/13/2015Q1$0.32$0.36$174.29 million$180.00 millionViewListenView Earnings Details
3/5/2015Q414$0.53$0.55$189.54 million$190.60 millionViewListenView Earnings Details
11/12/2014Q314$0.48$0.54$172.60 million$173.60 millionViewListenView Earnings Details
8/13/2014Q214$0.47$0.49$162.11 million$163.40 millionViewListenView Earnings Details
5/14/2014Q114$0.39$0.30$145.00 million$146.70 millionViewListenView Earnings Details
3/5/2014Q413$0.43$0.53$155.76 million$157.10 millionViewN/AView Earnings Details
11/13/2013Q313$0.39$0.47$145.29 million$146.70 millionViewListenView Earnings Details
8/12/2013Q2 2013$0.39$0.46$141.10 million$142.33 millionViewN/AView Earnings Details
5/13/2013Q1 2013$0.32$0.35$130.02 million$131.90 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.30$0.38$123.71 million$125.70 millionViewListenView Earnings Details
11/12/2012Q312$0.30$0.36$123.17 million$125.84 millionViewN/AView Earnings Details
8/13/2012$0.30$0.33ViewN/AView Earnings Details
5/10/2012$0.26$0.33ViewN/AView Earnings Details
3/8/2012$0.26$0.31ViewN/AView Earnings Details
11/10/2011$0.27$0.31ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


WuXi PharmaTech (Cayman) (NYSE:WX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for WuXi PharmaTech (Cayman) (NYSE:WX)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for WuXi PharmaTech (Cayman) (NYSE WX)

No insider trades for this company have been tracked by MarketBeat.com


WuXi PharmaTech (Cayman) (NYSE WX) News Headlines

When Exile Beats Chinas BackdoorWhen Exile Beats China's Backdoor
www.bloomberg.com - November 13 at 10:41 AM
Analyzing WuXi PharmaTech (Cayman) (WX) & PAREXEL International (PRXL)Analyzing WuXi PharmaTech (Cayman) (WX) & PAREXEL International (PRXL)
www.americanbankingnews.com - November 10 at 3:10 AM
WuXi PharmaTech (Cayman) (WX) and Organovo Holdings (ONVO) Head-To-Head AnalysisWuXi PharmaTech (Cayman) (WX) and Organovo Holdings (ONVO) Head-To-Head Analysis
www.americanbankingnews.com - November 8 at 9:32 PM
UPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth businessUPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth business
www.reuters.com - June 6 at 2:46 AM
Sky People Fruit Juice (An Update)Sky People Fruit Juice (An Update)
seekingalpha.com - January 9 at 3:22 PM
Form N-PX Managed Portfolio Series For: Jun 30Form N-PX Managed Portfolio Series For: Jun 30
www.streetinsider.com - August 22 at 8:17 PM
Chinas Banks Help Finance $157 Billion M&A SpreeChina's Banks Help Finance $157 Billion M&A Spree
www.bloomberg.com - August 9 at 8:40 PM
Viral Clearance Market Worth 510.3 Million USD by 2020Viral Clearance Market Worth 510.3 Million USD by 2020
www.marketwatch.com - April 4 at 10:45 AM

SEC Filings

WuXi PharmaTech (Cayman) (NYSE:WX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


WuXi PharmaTech (Cayman) (NYSE:WX) Income Statement, Balance Sheet and Cash Flow Statement


WuXi PharmaTech (Cayman) (NYSE WX) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.